-
- Sales of medical devices for elective procedures like spine and knee surgery lagged behind other medical device segments, which the company partially attributed to procedural backlogs.
-
- Johnson & Johnson’s U.S. orthopedics sales declined 4.5 percent compared to the same period in 2020.
-
- Hip device sales grew 2.3 percent globally compared to last year, while knee devices grew 2 percent.
-
- After introducing 17 medical devices in the first half of 2021, Johnson & Johnson introduced the Inhance Shoulder System in Q3 on Aug. 13.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
